Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism-Reference-Cited by-同舟云学术

Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism

Published:2016-05-05 Issue:6 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Sood Anup,Miller Alexandra M.,Brogi Edi,Sui Yunxia,Armenia Joshua,McDonough Elizabeth,Santamaria-Pang Alberto,Carlin Sean,Stamper Aleksandra,Campos Carl,Pang Zhengyu,Li Qing,Port Elisa,Graeber Thomas G.,Schultz Nikolaus,Ginty Fiona,Larson Steven M.,Mellinghoff Ingo K.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference45 articles.

1. The causes and consequences of genetic heterogeneity in cancer evolution

2. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

3. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

4. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

5. Subclonal diversification of primary breast cancer revealed by multiregion sequencing

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid multiplex immunohistochemistry for characterizing tumor-immune microenvironment;Heliyon;2024-07

2. A signature of enhanced proliferation associated with response and survival to anti-PD-L1 therapy in early-stage non-small cell lung cancer;Cell Reports Medicine;2024-03

3. Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial;Nature Communications;2023-12-19

4. Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level;Frontiers in Oncology;2022-07-29

5. Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma;Cell Reports;2022-04